source
- STAT+: GLP-1s are given an FDA warning for rare eye condition riskThe FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”STAT · 5h ago↗ source
- CVS split into two entities fails to address core issues in pharmacy benefit managementCVS Health is one of the largest U.S. companies, serving hundreds of millions of Americans and generating about $400 billion in annual revenue. It touches nearly every step of the drug supply chain…
- New studies highlight hurdles in lowering blood pressure after stroke or in diabetes patients